New cancer clinical trial: A Study of Napabucasin(GB201) in Combination With Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer

Published on: October 26, 2018 at 12:00PM
Condition:   Metastatic Pancreatic Cancer
Interventions:   Drug: Napabucasin;   Drug: Paclitaxel;   Drug: Gemcitabine;   Other: Standard of care treatment options
Sponsor:   1Globe Biomedical Co., Ltd.
Not yet recruiting
https://ift.tt/2SmpqID